Intellectual Property

  • July 10, 2006

    Congress Wary Of Tax Business Method Patents

    The U.S. Patent and Trademark Office is preparing to launch its defense on Capitol Hill of the existence of business method patents for tax procedures, after various patented tax schemes drew Congressional ire.

  • July 10, 2006

    Amgen Loses Battle In Anemia War With La Roche

    Marking another chapter in an epic battle over the multi-billion dollar market for anemia treatments, an judge with the International Trade Commission has rejected Amgen Inc.'s bid to bar rival drugmaker Hoffman-La Roche Inc.’s U.S. importation of peg-EPO.

  • July 10, 2006

    Klausner Targets Vonage In VoIP Infringement Suit

    Under fire for the third time in less than a year for its voice over Internet protocol technology, embattled telephone company Vonage Holdings Corp. has been slammed with a patent infringement suit by Klausner Technologies Inc.

  • July 10, 2006

    Rival Hits J2 Global With New Antitrust Suit

    Online fax and messenger service provider Venali Inc. has launched a counterattack against J2 Global Communications Inc., accusing its nemesis of violating federal antitrust, trademark competitiveness and patent laws related to the Internet fax market.

  • July 10, 2006

    Utah's "Clean Movie" Companies Illegitimate: Judge

    In a blow to companies that edit sex and swearing out of Hollywood movies, a district judge in Colorado has ruled such practices are illegal under copyright law, handing directors and movie studios a significant victory.

  • July 10, 2006

    Stinging Setback For Inventor In Patent Lawsuit

    A Chicago District Court judge ruled on June 28 that inventor Ole K. Nilssen had violated nearly every patent law on the books in his lawsuit against lighting company Osram Sylvania, Inc.

  • July 10, 2006

    Lawsuit Targets Director Of USPTO

    The Director of the U.S. Patent and Trademark Office is a defendant in a federal patent suit filed in Virginia by a subsidiary of Farmingdale, N.Y.-based biotech company Enzo Biochem Inc.

  • July 7, 2006

    J&J Subsidiaries Fight Back Generic Challenge

    Subsidiaries of Johnson & Johnson are suing a generic drug maker for patent infringement, hoping to block its attempts to market a generic version of a drug used to treat Alzheimer’s disease.

  • July 7, 2006

    DirecTV Socked With More Damages

    After being slammed with a $78.9 judgment for patent infringement, DirecTV Group Inc. is going to have to reach into its pocketbook again and pay hefty post-verdict damages.

  • July 7, 2006

    Defendants Cave To Acacia Over Resource Tools

    In a victory for patent-holding company Acacia Research Corp., two defendants in an infringement lawsuit have agreed to settle with the company over its technology for resource management software.

  • July 10, 2006

    Silicon Valley Counsel: HP's Jeffrey "Jeff" Fromm

    When Hewlett-Packard Corp.’s IP shepherd of forty years left the company in January, the computer maker was fortunate to have another long-time employee with IP expertise on hand to jump in.

  • July 7, 2006

    University, Nektar Settle Patent Feud For $25M

    Ending a dispute over biotech patents worth millions of dollars, the University of Alabama reached a $25 million settlement this week with biotechnology company Nektar Therapeutics in a case that highlighted the importance of clear rules concerning who owns academic inventions.

  • July 6, 2006

    Ruling Sets Up Patent Battle Over Growth Treatment

    Having recently won summary judgment on several of their motions, the makers of two growth hormone treatments for children are gearing up for a November trial against a rival company.

  • July 6, 2006

    Pepsi Helps Bust Sellers Of Coke Trade Secrets

    Not about to mess with its longtime rival’s coveted trade secrets, PepsiCo Inc. pointed authorities towards three people who stole confidential information about Coca-Cola Co.’s recipes and attempted to sell it to Pepsi.

  • July 7, 2006

    Silicon Valley Counsel: Xilinx's Thomas LaVelle

    For semiconductor maker Xilinx Inc., snatching Thomas LaVelle as its General Counsel may have been the biggest IP victory in its corporate history. LaVelle, one of the first lawyers at Intel, has used his Silicon Valley savvy to keep Xilinx remarkably clear of IP’s often choppy waters.

  • July 6, 2006

    Citizen Petitions Come Under Fire In Pharma War

    As generic drug makers continue to wrestle for their share of the pharmaceutical industry, the practice of filing citizen petitions has been attacked, with critics accusing brand name drug makers of exploiting the tool to unfairly shut generics out of the marketplace.

  • July 6, 2006

    Device Makers Settle Suit Over Incontinence Treatment

    A federal lawsuit alleging that a California-based medical device maker infringed on a patent covering treatments for female urinary incontinence has ended, after the two companies involved entered into a cross-licensing agreement.

  • July 6, 2006

    Oracle Launches Pre-Emptive Suit Against EpicRealm

    After filing a lawsuit against one of its customers and fearing it may be sued itself, enterprise software maker Oracle Corp. is looking to invalidate two patents for dynamic Web pages.

  • July 5, 2006

    Execs Charged With Peddling Trade Secrets

    Three former senior employees of Metaldyne Corporation have been charged with stealing secrets to help give its Chinese competitors a foothold as a supplier of powdered metal heavy automotive parts.

  • July 5, 2006

    Bank, Tech Co. Settle Over Digital Security Patent

    A lawsuit over digital security systems that pitted a technology company against a Silicon Valley bank has been settled, with Addison Avenue Federal Credit Union agreeing to license the patented system from Entrust Inc.